No phaseRecruitingAge-related condition

A prospective interventional study evaluating the anti-atherosclerotic effects of enhanced external counterpulsation therapy in individuals with atherosclerosis.

A prospective cohort study evaluating the anti-atherosclerotic effects of enhanced external counterpulsation therapy in a population with atherosclerosis

Sponsor

Peking University Third Hospital

Enrolment

20 planned

Conditions

Atherosclerosis

Interventions

The EECP group received standard EECP treatment; The control group received only conventional drug medication

Ages

adults, older adults

Registry

ChiCTR2600128240

Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed 20 July 2026